Identification of a Biomarker Signature to Predict the Need for Chemotherapy in Patients With Hormone Receptor Positive Breast Cancer

被引：0
|
作者：
Korf, U. [1 ]
Sonntag, J. [1 ]
Bender, C. [1 ]
Wiemann, S. [1 ]
Aulmann, S. [2 ]
Sinn, P. [2 ]
Burwinkel, B. [2 ]
Schneeweiss, A. [3 ]
Beissbarth, T. [4 ]
机构：
[1] German Canc Res Ctr, Heidelberg, Germany
[2] Univ Clin Heidelberg, Heidelberg, Germany
[3] Natl Ctr Tumor Dis Heidelberg, Gynecol Oncol Sect, Heidelberg, Germany
[4] Univ Med Ctr Gottingen, Gottingen, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)71480-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
847
引用
收藏
页码：S203 / S204
页数：2
相关论文
共 50 条
  • [41] Androgen Receptor in Hormone Receptor-Positive Breast Cancer
    Khan, Ashfia Fatima
    Karami, Samaneh
    Peidl, Anthony S.
    Waiters, Kacie D.
    Babajide, Mariam Funmi
    Bawa-Khalfe, Tasneem
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)
  • [42] Hormone-receptor expression and activity of trastuzumab with chemotherapy in HER2-positive advanced breast cancer patients
    Montemurro, Filippo
    Rossi, Valentina
    Rocca, Maria Cossu
    Martinello, Rossella
    Verri, Elena
    Redana, Stefania
    Adamoli, Laura
    Valabrega, Giorgio
    Sapino, Anna
    Aglietta, Massimo
    Viale, Giuseppe
    Goldhirsch, Aron
    Nole, Franco
    CANCER, 2012, 118 (01) : 17 - 26
  • [43] Patterns of chemotherapy receipt among patients with hormone receptor-positive, HER2-negative breast cancer
    Linnea T. Olsson
    Alina M. Hamilton
    Sarah C. Van Alsten
    Jennifer L. Lund
    Til Stürmer
    Hazel B. Nichols
    Katherine E. Reeder-Hayes
    Melissa A. Troester
    Breast Cancer Research and Treatment, 2024, 204 : 107 - 116
  • [44] Clinical Outcomes and Intrinsic Subtypes of Breast Cancer Patients with Single Hormone Receptor-positive Receiving Neoadjuvant Chemotherapy
    Wang, Tingting
    Wang, Jinnan
    Zhao, Wei
    Pan, Yueyin
    CLINICAL BREAST CANCER, 2024, 24 (05) : e370 - e378.e1
  • [45] The negative prognostic impact of downstaging after neoadjuvant chemotherapy in patients with hormone-receptor positive breast cancer.
    Takahashi, Yuko
    Hayashi, Naoki
    Matsuda, Naoko
    Kajiura, Yuka
    Yoshida, Atsushi
    Yagata, Hiroshi
    Nakamura, Seigo
    Suzuki, Koyu
    Tsunoda, Hiroko
    Yamauchi, Hideko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [46] Patterns of chemotherapy receipt among patients with hormone receptor-positive, HER2-negative breast cancer
    Olsson, Linnea T.
    Hamilton, Alina M.
    Van Alsten, Sarah C.
    Lund, Jennifer L.
    Sturmer, Til
    Nichols, Hazel B.
    Reeder-Hayes, Katherine E.
    Troester, Melissa A.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 204 (01) : 107 - 116
  • [47] Clinical Outcomes of Single Versus Double Hormone Receptor-Positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
    Raphael, Jacques
    Kiss, Alex
    Nofech-Mozes, Sharon
    Trudeau, Maureen
    CLINICAL BREAST CANCER, 2018, 18 (06) : E1381 - E1387
  • [48] Evaluating conventional pathological factors against the standardized 21-gene signature for hormone receptor positive breast cancer patients
    Onoda, T.
    Yamauchi, H.
    Yagata, H.
    Tsugawa, K.
    Suzuki, K.
    Nakamura, S.
    BREAST, 2011, 20 : S46 - S47
  • [49] Chemotherapy Use for Hormone Receptor-Positive, Lymph Node-Negative Breast Cancer
    Hassett, Michael J.
    Hughes, Melissa E.
    Niland, Joyce C.
    Edge, Stephen B.
    Theriault, Richard L.
    Wong, Yu-Ning
    Wilson, John
    Carter, W. Bradford
    Blayney, Douglas W.
    Weeks, Jane C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (34) : 5553 - 5560
  • [50] The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy
    Waks, Adrienne G.
    Stover, Daniel G.
    Guerriero, Jennifer L.
    Dillon, Deborah
    Barry, William T.
    Gjini, Evisa
    Hartl, Christina
    Lo, Wesley
    Savoie, Jennifer
    Brock, Jane
    Wesolowski, Robert
    Li, Zaibo
    Damicis, Adrienne
    Philips, Anne V.
    Wu, Yun
    Yang, Fei
    Sullivan, Amy
    Danaher, Patrick
    Brauer, Heather Ann
    Osmani, Wafa
    Lipschitz, Mikel
    Hoadley, Katherine A.
    Goldberg, Michael
    Perou, Charles M.
    Rodig, Scott
    Winer, Eric P.
    Krop, Ian E.
    Mittendorf, Elizabeth A.
    Tolaney, Sara M.
    CLINICAL CANCER RESEARCH, 2019, 25 (15) : 4644 - 4655
12345